A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Oncogene

• Publication date

  1997-05-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1201065PMID 9174055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.

  1996cited by this paper
• Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.

  1996cited by this paper
• Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.

  1995cited by this paper
• Direct selection of expressed sequences within a 1-Mb region flanking BRCA1 on human chromosome 17q21.

  1995cited by this paper
• The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1

  1995cited by this paper
• Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles.

  1995cited by this paper
• Microdissected double-minute DNA detects variable patterns of chromosomal localizations and multiple abundantly expressed transcripts in normal and leukemic cells.

  1994cited by this paper
• Type 1 protein phosphatase acts in opposition to IpL1 protein kinase in regulating yeast chromosome segregation

  1994cited by this paper
• Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.

  1994cited by this paper
• Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection

  1994cited by this paper
• Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression.

  1994cited by this paper
• Recent developments in the molecular genetic understanding of breast cancer.

  1994cited by this paper
• Long-term genome stability and minimal genotypic and phenotypic alterations in HPV16 E7-, but not E6-, immortalized human uroepithelial cells.

  1994cited by this paper
• Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.

  1994cited by this paper
• Isolation and characterization of chromosome-gain and increase-in-ploidy mutants in yeast.

  1993cited by this paper
• The selective isolation of novel cDNAs encoded by the regions surrounding the human interleukin 4 and 5 genes.

  1992cited by this paper
• Direct selection: a method for the isolation of cDNAs encoded by large genomic regions.

  1991cited by this paper
• Basic local alignment search tool.

  1990cited by this paper
• The structure and regulation of protein phosphatases.

  1989cited by this paper
• Protein serine/threonine kinases.

  1987cited by this paper

• An Aurora kinase A-BOD1L1-PP2A B56 axis promotes chromosome segregation fidelity

  2025cites this paper
• Advances in the design, discovery, and optimization of aurora kinase inhibitors as anticancer agents

  2025cites this paper
• Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat

  2025cites this paper
• Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties

  2024cites this paper
• eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer

  2024cites this paper
• Caspase-mediated AURKA cleavage at Asp132 is essential for paclitaxel to elicit cell apoptosis

  2024cites this paper
• RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development.

  2024cites this paper
• Proteomic study identifies Aurora-A–mediated regulation of alternative splicing through multiple splicing factors

  2024cites this paper
• Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features

  2024cites this paper
• An Aurora kinase A-BOD1L1-PP2A B56 Axis promotes chromosome segregation fidelity

  2023cites this paper
• Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours

  2023cites this paper
• Aurora kinases: Generators of spatial control during mitosis

  2023cites this paper
• Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence

  2023cites this paper
• The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics

  2023cites this paper
• PP6 regulation of Aurora A–TPX2 limits NDC80 phosphorylation and mitotic spindle size

  2023cites this paper
• Metabolic protein kinase signalling in neuroblastoma

  2023cites this paper
• The involvement of Aurora‐A and p53 in oxaliplatin‐resistant colon cancer cells

  2023cites this paper
• Aurora Kinases as Therapeutic Targets in Head and Neck Cancer.

  2022cites this paper
• Estrogen receptor 1 and Aurora kinase A as potential diagnostic biomarkers for cervical cancer

  2022cites this paper
• Cordycepin and kinase inhibition in cancer.

  2022cites this paper
• PP6-regulated Aurora A activity towards NDC80 limits mitotic spindle size to prevent micronucleation

  2022cites this paper
• Identification of key genes in oral squamous cell carcinoma by integrated bioinformatics analysis

  2022cites this paper
• From Synthetic Simplified Marine Metabolite Analogues to New Selective Allosteric Inhibitor of Aurora B Kinase.

  2021cites this paper
• Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression

  2021cites this paper
• Targeting AURKA by microRNA-490-3p suppresses gastric cancer cell growth.

  2021cites this paper
• Design, synthesis and molecular docking study of new purine derivatives as Aurora kinase inhibitors

  2021cites this paper
• Increased expression levels of AURKA and KIFC1 are promising predictors of progression and poor survival associated with gastric cancer.

  2021cites this paper
• Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer

  2021cites this paper
• ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21

  2021cites this paper
• Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer

  2021cites this paper
• Epigenetic Regulator Enzymes and Their Implications in Distinct Malignancies

  2020cites this paper
• Automated screening of AURKA activity based on a genetically encoded FRET biosensor using fluorescence lifetime imaging microscopy

  2020cites this paper
• Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy

  2020cites this paper
• Transcriptome profiling of developing testes and spermatogenesis in the Mongolian horse

  2020cites this paper
• Aurora-A phosphorylates splicing factors and regulates alternative splicing

  2020cites this paper
• The role of Aurora-A in human cancers and future therapeutics.

  2020cites this paper
• Identification and characterization of drug resistance mechanisms in cancer cells against Aurora kinase inhibitors CYC116 and ZM447439

  2020cites this paper
• Suppression of multiple processes relevant to cancer progression by benzyl isothiocyanate may result from the inhibition of Aurora A kinase activity.

  2020cites this paper
• Cyclopenta[b]indole Derivative Inhibits Aurora B in Primary Cells

  2020cites this paper
• A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours

  2020cites this paper
• Dual Targeting of the Mesenchymal and Amoeboid Pathways: A Viable Therapy against Metastatic Breast Cancer

  2019cites this paper
• Sending mixed signals: Cilia-dependent signaling during development and disease.

  2019cites this paper
• hnRNPK S379 phosphorylation participates in migration regulation of triple negative MDA-MB-231 cells

  2019cites this paper
• A new role for Drosophila Aurora-A in maintaining chromosome integrity

  2019cites this paper
• Understanding aspects behind recombination-dependent telomere maintenance and chromosome circularization using fission yeast

  2019cites this paper
• Aurora kinases: novel anti-breast cancer targets

  2019cites this paper
• The role of aurora A and polo-like kinases in high-risk lymphomas.

  2019cites this paper
• Transcriptome profiling of developing testes and spermatogenesis in Mongolian horse

  2019cites this paper
• AURKA rs8173 G>C Polymorphism Decreases Wilms Tumor Risk in Chinese Children

  2019cites this paper
• Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review.

  2019cites this paper
• The functional diversity of Aurora kinases: a comprehensive review

  2018cites this paper
• A Step Closer to Precision Oncology: Computational, Biochemical, and Cell-Based Screening to Find Compounds that Stabilize p53

  2018cites this paper
• Tozasertib Analogues as Inhibitors of Necroptotic Cell Death.

  2018cites this paper
• Aurora A and cancer

  2018cites this paper
• Kinase-targeted cancer therapies: progress, challenges and future directions

  2018cites this paper
• Aurora A inhibition limits centrosome clustering and promotes mitotic catastrophe in cells with supernumerary centrosomes

  2018cites this paper
• Potential new biomarkers for squamous carcinoma of the uterine cervix

  2018cites this paper
• Targeting mitotic pathways for endocrine-related cancer therapeutics.

  2017cites this paper
• Computationally-guided optimization of small-molecule inhibitors of the Aurora A kinase–TPX2 protein–protein interaction

  2017cites this paper
• The Effect of Aurora Kinase Inhibitor on Adhesion and Migration in Human Breast Cancer Cells and Clinical Implications

  2017cites this paper
• Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan

  2017cites this paper
• of Chromosomes Instability in Different Diseases as Accessed on Illumina Miseq Platform using Depth of Coverage Metrics for Variant Evaluation by GATK

  2017cites this paper
• The Role of Aurora Kinase A ( AURKA ) in Regulating Translation of Oncogenes in Gastrointestinal Cancers

  2017cites this paper
• Inhibition of Aurora Kinase A Synergistically Enhances Cytotoxicity in Ovarian Clear Cell Carcinoma Cell Lines Induced by Cisplatin: A Potential Treatment Strategy

  2017cites this paper
• The Role of Human Papillomaviruses in the Aetiopathogenesis of Head and Neck Cancer in South Asia, and Approaches to Treatment

  2017cites this paper
• Aurora A Kinase Is a Priority Pharmaceutical Target for the Treatment of Cancers.

  2017cites this paper
• A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.

  2017cites this paper
• Étude du rôle de la kinase Aurora-A dans le développement de la larve et du cerveau de Drosophila melanogaster

  2017influential citation
• APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model

  2017cites this paper
• Synthesis and structure elucidation of polyphenols containing the N′‐methyleneformohydrazide scaffold as aurora kinase inhibitors

  2017cites this paper
• Association between the functional polymorphism Ile31Phe in the AURKA gene and susceptibility of hepatocellular carcinoma in chronic hepatitis B virus carriers

  2017cites this paper
• RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy

  2016cites this paper
• The Ski Protein is Involved in the Transformation Pathway of Aurora Kinase A

  2016cites this paper
• CHAPTER 4 The Identification of New Aurora A Kinase Inhibitors by Pharmacophore Modeling , Virtual Screening and Molecular Docking

  2016cites this paper
• Aurora kinase A induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity.

  2016cites this paper
• Are Accurins the cure for Aurora kinase inhibitors?

  2016cites this paper
• Aurora Kinase A and Gastrointestinal Malignancies

  2016cites this paper
• MLN-8237: A dual inhibitor of aurora A and B in soft tissue sarcomas

  2016cites this paper
• Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.

  2016cites this paper
• New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase

  2016cites this paper
• A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy

  2016cites this paper
• Aurora‐A Kinase: A Potent Oncogene and Target for Cancer Therapy

  2016cites this paper
• Aurora kinase A activates the vacuolar H+-ATPase (V-ATPase) in kidney carcinoma cells.

  2016cites this paper
• Clear cell renal cell carcinoma: identifying the gain of chromosome 20 on multiphasic MDCT

  2016cites this paper
• Satellite Cells in Muscular Dystrophy - Lost in Polarity.

  2016cites this paper
• Aurora-A: an expedition to the pole of the spindle in Xenopus egg extracts.

  2016cites this paper
• Association of CYP2E1, STK15 and XRCC1 Polymorphisms with Risk of Breast Cancer in Malaysian Women.

  2016cites this paper
• Design and synthesis of imidazo[4,5-c]pyridine derivatives as promising Aurora kinase A (AURKA) inhibitors

  2016cites this paper
• Cross-Talk between AURKA and Plk1 in Mitotic Entry and Spindle Assembly

  2015cites this paper
• Emerging therapeutic targets in bladder cancer.

  2015cites this paper
• The role of intratumour heterogeneity and chromosomal instability in cancer

  2015cites this paper
• The Dawn of Aurora Kinase Research: From Fly Genetics to the Clinic

  2015cites this paper
• The Clinical Development of Aurora Kinase Inhibitors in Acute Myeloid Leukemia

  2015cites this paper
• Aurora kinase A in gastrointestinal cancers: time to target

  2015cites this paper
• A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors

  2015cites this paper
• Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer

  2015cites this paper
• Korrelation von TP53 Mutation und Stk15 Polymorphismus in Bezug auf Überleben von Patienten mit Plattenepithelkarzinomen im Kopf-Hals-Bereich

  2015cites this paper
• Aurora kinases are essential for PKC-induced invasion and matrix metalloproteinase-9 expression in MCF-7 breast cancer cells.

  2015cites this paper
• Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features.

  2014cites this paper
• Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer

  2014cites this paper